Verona Pharma Plc Stock Price Prediction

VRNA Stock  USD 62.39  3.21  4.89%   
The relative strength index (RSI) of Verona Pharma's stock price is about 64. This entails that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Verona, making its price go up or down.

Momentum 64

 Buy Extended

 
Oversold
 
Overbought
The successful prediction of Verona Pharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Verona Pharma PLC, which may create opportunities for some arbitrage if properly timed.
Using Verona Pharma hype-based prediction, you can estimate the value of Verona Pharma PLC from the perspective of Verona Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Verona Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Verona because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Verona Pharma after-hype prediction price

    
  USD 62.39  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Verona Pharma Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
45.2048.5968.63
Details
Naive
Forecast
LowNextHigh
61.0964.4867.87
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
57.8562.7167.56
Details

Verona Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Verona Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Verona Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Verona Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Verona Pharma Estimiated After-Hype Price Volatility

In the context of predicting Verona Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Verona Pharma's historical news coverage. Verona Pharma's after-hype downside and upside margins for the prediction period are 59.00 and 65.78, respectively. We have considered Verona Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
62.39
62.39
After-hype Price
65.78
Upside
Verona Pharma is very steady at this time. Analysis and calculation of next after-hype price of Verona Pharma PLC is based on 3 months time horizon.

Verona Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Verona Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Verona Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Verona Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.82 
3.39
 0.00  
  0.08 
0 Events / Month
9 Events / Month
Any time
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
62.39
62.39
0.00 
0.00  
Notes

Verona Pharma Hype Timeline

Verona Pharma PLC is at this time traded for 62.39. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.08. Verona is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.82%. %. The volatility of related hype on Verona Pharma is about 3557.41%, with the expected price after the next announcement by competition of 62.47. About 88.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 2.0. Verona Pharma PLC had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be any time.
Check out Verona Pharma Basic Forecasting Models to cross-verify your projections.

Verona Pharma Related Hype Analysis

Having access to credible news sources related to Verona Pharma's direct competition is more important than ever and may enhance your ability to predict Verona Pharma's future price movements. Getting to know how Verona Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Verona Pharma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
VTYXVentyx Biosciences(0.05)9 per month 0.00 (0.01) 11.35 (7.56) 35.02 
IDYAIdeaya Biosciences(0.53)7 per month 0.00 (0.11) 4.37 (4.64) 13.32 
PTGXProtagonist Therapeutics 0.42 7 per month 0.00 (0.06) 3.48 (4.10) 18.65 
SNDXSyndax Pharmaceuticals(0.20)10 per month 0.00 (0.02) 5.59 (4.75) 12.74 
DAWNDay One Biopharmaceuticals(0.13)11 per month 0.00 (0.06) 3.92 (3.28) 10.17 
XFORX4 Pharmaceuticals(0.05)9 per month 7.11  0.07  26.42 (13.51) 68.45 
INZYInozyme Pharma 0.02 6 per month 0.00 (0.20) 7.72 (8.61) 38.13 
ABOSAcumen Pharmaceuticals(0.06)6 per month 0.00 (0.19) 6.70 (6.19) 15.46 
MREOMereo BioPharma Group(0.04)6 per month 0.00 (0.09) 6.16 (6.32) 20.77 
TERNTerns Pharmaceuticals(0.37)7 per month 0.00 (0.16) 5.17 (6.98) 26.61 
AMLXAmylyx Pharmaceuticals 0.00 0 per month 0.00 (0.25) 5.85 (7.94) 16.76 
MLTXMoonLake Immunotherapeutics 0.00 0 per month 0.00 (0.14) 5.64 (5.69) 13.46 
MRTXMirati Ther 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
APLSApellis Pharmaceuticals 0.00 0 per month 0.00 (0.11) 4.57 (4.54) 21.42 
AKROAkero Therapeutics(0.38)9 per month 2.68  0.1  4.92 (5.05) 103.16 
MDGLMadrigal Pharmaceuticals 1.83 10 per month 3.52  0.02  5.28 (4.35) 15.92 
VKTXViking Therapeutics 1.16 9 per month 0.00 (0.16) 4.89 (7.34) 24.65 

Verona Pharma Additional Predictive Modules

Most predictive techniques to examine Verona price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Verona using various technical indicators. When you analyze Verona charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Verona Pharma Predictive Indicators

The successful prediction of Verona Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Verona Pharma PLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Verona Pharma based on analysis of Verona Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Verona Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Verona Pharma's related companies.

Story Coverage note for Verona Pharma

The number of cover stories for Verona Pharma depends on current market conditions and Verona Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Verona Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Verona Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Verona Pharma Short Properties

Verona Pharma's future price predictability will typically decrease when Verona Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Verona Pharma PLC often depends not only on the future outlook of the potential Verona Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Verona Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding634.1 M
Cash And Short Term Investments271.8 M

Complementary Tools for Verona Stock analysis

When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas